See also this year's filing and all EDGAR filings for this company.
PDF Report 0001728328_2023_InMed_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001728328, InMed Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 9,597,776 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,108,915 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,080,889 |
| 4 | LiabilitiesCurrent | 3,319,541 |
| 5 | LiabilitiesNoncurrent | 389,498 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 545,889 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,867,030 |
| 9 | ResearchAndDevelopmentExpense | 7,282,615 |
| 10 | remainder_Expenses | 4,972,557 |
| 11 | remainder_Revenues | 1,089,435 |
| 12 | remainder_NetIncome | -21,461 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,787,580 |
| 1 | Liabilities | 3,709,039 |
| 2 | Expenses | 19,668,091 |
| 3 | Revenues | 1,089,435 |
| 4 | StockholdersEquity | 9,078,541 |
| 5 | NetIncome | -18,600,117 |
| 6 | ComprehensiveNetIncome | -18,600,117 |
| 7 | BaseVar | 18,637,803 |
| 8 | EconomicCapitalRatio | -0.362 |
Edgar->Model Mapping
Feature Distribution
Change over Time
